At this period of complete remission, human CD44 transcripts are detected by semiquantitative nested RT–PCR, in the fat pads at the site of the tumour graft (detection threshold huCD44+ cells: one in every 107 cells) (Figure 2B), showing that at least a fraction of CD44+ cells were resistant to AC. The gene discussed is CD44; the disease is neoplasm.